Contracts › HT942523C0036
HT942523C0036: Intranasal Treatment for Mild Traumatic Brain Injury (Broad Agency Announcement Number SO190192)
Awarded to Beyond Barriers Therapeutics, Inc. by Defense Health Agency.
$1.9Mobligated
$1.9Mpotential value
24 January 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HT942523C0036 |
|---|---|
| Awardee | Beyond Barriers Therapeutics, Inc. |
| Awarding agency | Defense Health Agency |
| Awarding office | DEFENSE HEALTH AGENCY |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | IL |
| Offers received | 999 |
| Period of performance | 25 July 2023 to 24 January 2027 |
| Potential end | 24 January 2027 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record